haitong int'l: Taotian brand-driven, TikTok gift box bestsellers november 11 shopping festival-related cosmetics leader multi-platform growth

During the november 11 shopping festival-related, Douyin achieved high growth with an increased share of commodity cards; the contribution of the Taotian platform's GMV exceeded 50%, and brand collaboration created additional growth. The growth momentum of domestic products is strong, with leading brands experiencing multiple bursts of activity.

Zhitong FinanceNov 20 02:46 ET

Here's Why Giant Biogene Holding (HKG:2367) Has Caught The Eye Of Investors

Simply Wall StNov 17 22:04 ET

[Brokerage Focus] CMB International raises target price for Giant Sons (02367) by 6.6%, highlighting strong online growth of two core brands during singles' day sales.

Jingu Financial News | CICC issued research reports stating that during singles' day sales, JuZiBiotech (02367) saw strong growth in online sales of its two core brands KeFuMei and KeLiJin. The online omni-channel GMV of KeFuMei and KeLiJin increased by over 80% and over 150% respectively year-on-year, showing faster growth compared to this year's "618". KeFuMei and KeLiJin experienced explosive growth on the Douyin platform, with year-on-year growth of over 100% and over 500% respectively during singles' day sales. KeFuMei's collagen sticks continued high growth with impressive performance of new products. KeLiJin intensified its new product efforts, rapidly releasing growth potential. The bank believes that the continuously enriched product matrix will drive long-term brand growth.

Jingu Financial NewsNov 14 00:32 ET

CMB International: Maintains a "buy" rating on Genscript Biotech (02367) with a target price of 66.15 Hong Kong dollars.

CMB International remains bullish on the rapid growth of JuZi Biotech's skincare products, expecting collagen injection products to be approved in 1Q25E.

Zhitong FinanceNov 13 20:51 ET

Pu silver International: The sales of beauty products during the november 11 shopping festival-related are growing well, and domestic brands are stable under a high base.

With the overall e-commerce sales picking up, this time the beauty sector performed well in the november 11 shopping festival-related.

Zhitong FinanceNov 13 00:40 ET

Most pharmaceutical stocks rose, with Tongyuan Kangyi Medicine (02410) up 18.46%. Institutions pointed out that the policy trend of medical insurance funds supporting innovative drugs will not change.

Jingwu Cai Xun | Most pharmaceutical stocks rose, with Tongyuan Kang Medicine (02410) up 18.46%, Keji Pharmaceutical (02171) up 13.86%, Heyu (02256) up 11.79%, Cloud Peak Xin Yao (01952) up 10.31%, cansinobio (06185) up 7.48%. Zhong Yin International stated that benefiting from overseas interest rate cuts and domestic macroeconomic improvement, the pharmaceutical industry, as a high elasticity industry, is expected to outperform the market. The bank believes that the performance of the macroeconomy is closely related to the revenue and expenditure of medical insurance funds and medical health consumer spending. As policy focus shifts to stimulating the economy, the bank believes that medical industry

Golden Guardian Financial NewsNov 8 01:59 ET